Y-mAbs Therapeutics Inc (NAS:YMAB)
$ 11.85 -0.33 (-2.71%) Market Cap: 520.01 Mil Enterprise Value: 459.92 Mil PE Ratio: 0 PB Ratio: 5.24 GF Score: 56/100

Y-mAbs Therapeutics Inc (YMAB) Transcripts

  • 1